V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003059 | 280002314 | null | 73.6 | Curative (C) | null | 2016-03-15 | Doxorubicin + Ifosfamide | N | N | 280024903 | DOXORUBICIN + IFOSFAMIDE |
| 280003060 | 280002315 | 1.74 | 81.2 | null | 2016-12-10 | 2017-06-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024907 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003061 | 280002316 | 1.8 | 91 | Neo-adjuvant (N) | 2016-10-18 | 2016-10-18 | Doxorubicin + Ifosfamide | 2 | N | 280024910 | DOXORUBICIN + IFOSFAMIDE |
| 280003062 | 280002317 | null | 105.25 | Neo-adjuvant (N) | 2013-10-29 | 2013-11-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280024911 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003063 | 280002318 | 168 | 69.1 | Neo-adjuvant (N) | 2015-09-21 | 2015-09-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280024913 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003064 | 280002318 | 1.7 | 98.9 | Neo-adjuvant (N) | null | 2016-04-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024913 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003065 | 280002319 | 1.84 | 128 | Neo-adjuvant (N) | null | 2016-02-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024915 | CISPLATIN + FLUOROURACIL |
| 280003066 | 280007227 | 1.68 | 68.9 | Palliative (P) | 2015-05-13 | 2015-05-30 | DOXORUBICIN + IFOSFAMIDE | N | N | 280024916 | DOXORUBICIN + IFOSFAMIDE |
| 280003067 | 280007227 | 1.81 | 81.2 | null | 2015-11-25 | 2015-11-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024916 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003068 | 280002320 | 1.65 | 45.9 | Curative (C) | 2016-03-16 | 2016-03-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280024920 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003069 | 280002321 | 1.67 | 76.4 | Not known (9) | null | 2017-04-03 | CETUXIMAB + RT | null | null | 280024922 | CETUXIMAB + RT |
| 280003070 | 280002322 | null | null | Curative (C) | 2013-08-31 | 2013-08-31 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024924 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003071 | 280002323 | 1.72 | 101.5 | Neo-adjuvant (N) | 2016-02-07 | 2016-02-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024926 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003072 | 280002324 | 1.8 | 96.3 | Curative (C) | 2015-07-24 | 2015-08-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280024927 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003073 | 280002324 | 1.61 | 105.4 | Neo-adjuvant (N) | 2014-09-14 | 2014-09-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024927 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003074 | 280002324 | null | 83.9 | Neo-adjuvant (N) | 2013-07-21 | 2013-07-21 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280024927 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003075 | 280002324 | 1.72 | 69.8 | Neo-adjuvant (N) | 2014-01-22 | 2014-02-04 | Cisplatin + Docetaxel +Fluorouracil | N | null | 280024927 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003076 | 280002325 | 1.71 | 79 | Curative (C) | 2013-02-20 | 2013-02-28 | CETUXIMAB + RT | 02 | null | 280024931 | CETUXIMAB + RT |
| 280003077 | 280007229 | 1.72 | null | null | 2017-12-11 | 2018-01-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024933 | CISPLATIN + FLUOROURACIL |
| 280003078 | 280002326 | 1.72 | 75.1 | Neo-adjuvant (N) | 2016-04-09 | 2016-04-23 | Cisplatin +Fluorouracil (3 wk) | null | null | 280024936 | CISPLATIN + FLUOROURACIL |
| 280003079 | 280007230 | 1.6 | 70 | Curative (C) | 2014-06-07 | 2014-06-27 | Cetuximab + Radiotherapy Load | N | Y | 280024937 | CETUXIMAB + RT |
| 280003080 | 280002327 | null | 58.1 | Adjuvant (A) | 2014-02-15 | 2014-02-21 | Doxorubicin + Ifosfamide | N | null | 280024942 | DOXORUBICIN + IFOSFAMIDE |
| 280003081 | 280002328 | 1.86 | 96.6 | null | 2018-01-29 | 2018-01-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024943 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003082 | 280002329 | 1.79 | 57 | Neo-adjuvant (N) | 2015-10-12 | 2015-10-22 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 280024944 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003084 | 280002331 | 1.77 | 105 | Curative (C) | 2016-05-07 | 2016-05-11 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280024948 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003085 | 280002332 | 1.8 | 91.9 | null | 2014-06-24 | 2014-11-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024949 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003086 | 280002333 | null | null | Neo-adjuvant (N) | 2013-08-29 | 2013-09-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024950 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003087 | 280002334 | 0 | 67.5 | Neo-adjuvant (N) | 2016-06-29 | 2016-07-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024952 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003088 | 280002335 | null | null | Neo-adjuvant (N) | 2011-03-20 | 2013-05-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024953 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003089 | 280002335 | 1.62 | null | Neo-adjuvant (N) | 2017-07-17 | 2017-08-13 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024953 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003090 | 280002336 | 1.65 | 57.2 | Adjuvant (A) | null | 2014-05-13 | Doxorubicin + Ifosfamide | N | N | 280024955 | DOXORUBICIN + IFOSFAMIDE |
| 280003091 | 280002337 | 1.63 | 52 | Neo-adjuvant (N) | 2014-03-26 | 2014-03-30 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280024956 | CISPLATIN + FLUOROURACIL |
| 280003092 | 280002338 | 1.6 | null | Neo-adjuvant (N) | 2015-12-01 | 2016-03-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024957 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003093 | 280002338 | 1.76 | null | Curative (C) | 2017-09-12 | 2017-09-15 | CISPLATIN + FLUOROURACIL | null | null | 280024957 | CISPLATIN + FLUOROURACIL |
| 280003094 | 280002339 | 1.52 | 77 | Curative (C) | null | 2013-06-01 | CETUXIMAB + RT | N | N | 280024961 | CETUXIMAB + RT |
| 280003095 | 280002340 | 1.55 | 89.2 | Neo-adjuvant (N) | 2014-01-02 | 2014-01-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024962 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003096 | 280002341 | 1.6 | null | Curative (C) | 2013-02-28 | 2013-03-01 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024963 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003097 | 280002342 | 1.97 | 87.8 | Curative (C) | 2017-05-27 | 2017-07-06 | Cetuximab + Radiotherapy Maint | 02 | N | 280024966 | CETUXIMAB + RT |
| 280003098 | 280002343 | 1.67 | 97 | Neo-adjuvant (N) | 2014-06-28 | 2014-06-28 | Cisplatin + Docetaxel +Fluorouracil | 01 | null | 280024968 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003099 | 280002343 | 1.71 | 96 | Neo-adjuvant (N) | 2017-11-15 | 2017-11-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280024968 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003100 | 280002344 | 1.8 | 85 | Neo-adjuvant (N) | 2015-03-06 | 2015-03-11 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280024974 | CISPLATIN + FLUOROURACIL |
| 280003101 | 280002344 | 1.72 | null | Neo-adjuvant (N) | 2014-04-03 | 2014-04-13 | CISPLATIN + FLUOROURACIL | 02 | N | 280024974 | CISPLATIN + FLUOROURACIL |
| 280003102 | 280002344 | 1.58 | 65 | Neo-adjuvant (N) | 2015-01-02 | 2015-01-02 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 280024974 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003103 | 280002345 | 1.74 | 67.5 | Palliative (P) | 2013-05-29 | 2013-06-08 | Doxorubicin + Ifosfamide | N | N | 280024981 | DOXORUBICIN + IFOSFAMIDE |
| 280003104 | 280002346 | 1.69 | 85.5 | Curative (C) | 2013-10-30 | 2013-11-07 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280024982 | CISPLATIN + FLUOROURACIL |
| 280003105 | 280002347 | 1.71 | 72.4 | Adjuvant (A) | 2015-09-20 | 2015-10-09 | DOXORUBICIN + IFOSFAMIDE | 2 | N | 280024984 | DOXORUBICIN + IFOSFAMIDE |
| 280003106 | 280002348 | 1.71 | 64 | Curative (C) | 2017-01-24 | 2017-02-13 | Cetuximab + Radiotherapy Load | 02 | Y | 280024986 | CETUXIMAB + RT |
| 280003107 | 280002349 | 2 | 102.3 | Curative (C) | 2017-04-23 | 2017-04-23 | Cetuximab + Radiotherapy Load | 02 | N | 280024990 | CETUXIMAB + RT |
| 280003108 | 280002349 | 1.64 | 67.5 | Curative (C) | 2013-04-25 | 2013-05-12 | CETUXIMAB + RT | N | Y | 280024990 | CETUXIMAB + RT |
| 280003109 | 280002349 | 1.73 | 70 | Curative (C) | 2013-10-30 | 2013-11-03 | CETUXIMAB + RT | N | N | 280024990 | CETUXIMAB + RT |